References
- Bayer HealthCare LLC. Produktmonographie Perfalgan: Bayer. 2002
- Brown M A, McCowan L M, North R A, Walters B N. Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy. Medical Journal of Australia 1997; 166: 640–643
- Ferguson J E, 2nd, Schutz T, Pershe R, Stevenson D K, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. American Journal of Obstetrics and Gynecology 1989; 161: 1485–1490
- Furberg C D, Psaty B M. Corrections to the nifedipine meta-analysis. Circulation 1996; 93: 1475–1476
- Furberg C D, Psaty B M, Meyer J V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326–1331
- Grundy J S, Foster R T. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clinical pharmacokinetics 1996; 30: 28–51
- King J F, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Australian and New Zealand. Journal of Obstetrics and Gynaecology 2003; 43: 192–198
- Oei S G, Mol B W, de Kleine M J, Brolmann H A. Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 1999; 78: 783–788
- Pirhonen J P, Erkkola R U, Ekblad U U, Nyman L. Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms. Obstetrics and Gynecology 1990; 76: 807–811
- Psaty B M, Heckbert S R, Koepsell T D, Siscovick D S, Raghunathan T E, Weiss N S, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. Journal of the American Medical Association 1995; 274: 620–625
- Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 1997; 52: 895–911
- Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstetrics and Gynecology 2001; 97: 840–847
- van Veen A J, Pelinck M J, van Pampus M G, Erwich J J. Severe hypotension and fetal death due to tocolysis with nifedipine. British Journal of Obstetrics and Gynaecology 2005; 112: 509–510